Epilepsy, a chronic neurological disorder characterized by recurrent, unprovoked seizures, has seen significant advancements in its management over recent years. This article aims to provide a comprehensive update on these recent developments.
Several new AEDs have been introduced in the last decade. These drugs, including Brivaracetam, Perampanel, and Stiripentol, offer improved seizure control, better tolerability, and fewer drug interactions. They have broadened the therapeutic options for clinicians, particularly for refractory epilepsy.
There has been a significant evolution in epilepsy surgery. Minimally invasive techniques, such as laser interstitial thermal therapy (LITT) and stereotactic EEG-guided resection, have demonstrated efficacy in reducing seizure frequency and severity. These techniques offer a safer and more tolerable alternative to traditional resective surgery.
Neuromodulation therapies, including vagus nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS), have emerged as promising treatment options for drug-resistant epilepsy. These therapies modulate neuronal activity, reducing seizure frequency and improving quality of life.
Advancements in genetic testing have led to the identification of numerous epilepsy-associated genes, facilitating precision medicine. Tailoring treatment based on a patient's genetic profile can optimize efficacy and minimize adverse effects, offering a personalized approach to epilepsy management.
In conclusion, the field of epilepsy management has seen significant advancements, with new AEDs, improved surgical techniques, neuromodulation therapies, and the advent of precision medicine. These developments have expanded treatment options, improved patient outcomes, and provided a more personalized approach to care. It is essential for healthcare professionals to keep abreast of these advancements to provide optimal care to their patients.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation